In many cases, this has been due to issues with study design, such as: small sample sizes short follow-up durations differences in PRP preparation, administration, and dosages between studies large differences in the time between individual PRP treatments between studies inclusion of data from studies other than randomized controlled trials (RCTs) potential experimenter bias, or lack of blinding However, researchers continue to study PRPs effectiveness using high quality, large-scale RCTs
In general terms, initial dosing tends to begin at the lower end of an established range to assess tolerability, with adjustment directed by the provider based on response and side effects
For midlife and menopausal skin, I would absolutely call this a top-tier formula as long as you tolerate it well, stay consistent, and use mindful sun practices
Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes